BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 15378020)

  • 1. DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway.
    Niida A; Hiroko T; Kasai M; Furukawa Y; Nakamura Y; Suzuki Y; Sugano S; Akiyama T
    Oncogene; 2004 Nov; 23(52):8520-6. PubMed ID: 15378020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.
    Jho EH; Zhang T; Domon C; Joo CK; Freund JN; Costantini F
    Mol Cell Biol; 2002 Feb; 22(4):1172-83. PubMed ID: 11809808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S; Bapat B
    Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2.
    Hussein SM; Duff EK; Sirard C
    J Biol Chem; 2003 Dec; 278(49):48805-14. PubMed ID: 14551209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The control of beta-catenin and TCF during embryonic development and cancer.
    Waltzer L; Bienz M
    Cancer Metastasis Rev; 1999; 18(2):231-46. PubMed ID: 10728986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development.
    Chamorro MN; Schwartz DR; Vonica A; Brivanlou AH; Cho KR; Varmus HE
    EMBO J; 2005 Jan; 24(1):73-84. PubMed ID: 15592430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative genomics on Dkk1 orthologs.
    Katoh Y; Katoh M
    Int J Oncol; 2005 Jul; 27(1):275-9. PubMed ID: 15942669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.
    Sampson EM; Haque ZK; Ku MC; Tevosian SG; Albanese C; Pestell RG; Paulson KE; Yee AS
    EMBO J; 2001 Aug; 20(16):4500-11. PubMed ID: 11500377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a mouse homolog of the human BTEB2 transcription factor as a beta-catenin-independent Wnt-1-responsive gene.
    Ziemer LT; Pennica D; Levine AJ
    Mol Cell Biol; 2001 Jan; 21(2):562-74. PubMed ID: 11134343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
    Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
    Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brachyury is a target gene of the Wnt/beta-catenin signaling pathway.
    Arnold SJ; Stappert J; Bauer A; Kispert A; Herrmann BG; Kemler R
    Mech Dev; 2000 Mar; 91(1-2):249-58. PubMed ID: 10704849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatin-specific regulation of LEF-1-beta-catenin transcription activation and inhibition in vitro.
    Tutter AV; Fryer CJ; Jones KA
    Genes Dev; 2001 Dec; 15(24):3342-54. PubMed ID: 11751639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replicating parvoviruses that target colon cancer cells.
    Malerba M; Daeffler L; Rommelaere J; Iggo RD
    J Virol; 2003 Jun; 77(12):6683-91. PubMed ID: 12767988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation.
    Daniels DL; Weis WI
    Nat Struct Mol Biol; 2005 Apr; 12(4):364-71. PubMed ID: 15768032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt/beta-catenin signaling suppresses apoptosis in low serum medium and induces morphologic change in rodent fibroblasts.
    Ueda Y; Hijikata M; Takagi S; Takada R; Takada S; Chiba T; Shimotohno K
    Int J Cancer; 2002 Jun; 99(5):681-8. PubMed ID: 12115501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
    Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
    Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.
    Jho Eh; Lomvardas S; Costantini F
    Biochem Biophys Res Commun; 1999 Dec; 266(1):28-35. PubMed ID: 10581160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF.
    Hamada F; Bienz M
    Dev Cell; 2004 Nov; 7(5):677-85. PubMed ID: 15525529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCF-4 binds beta-catenin and is expressed in distinct regions of the embryonic brain and limbs.
    Cho EA; Dressler GR
    Mech Dev; 1998 Sep; 77(1):9-18. PubMed ID: 9784592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation.
    Spychala J; Kitajewski J
    Exp Cell Res; 2004 Jun; 296(2):99-108. PubMed ID: 15149841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.